Ethyl Acetate

Ethyl Acetate

SCHEMBL58573

CCOC(C)=O.ClCCl.ClCCl.ClCCl.ClCCl.ClCCl.ClCCl.ClCCl.ClCCl.ClCCl.ClCCl

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.82
LMNA P02545 1/20 0.82
HSD17B10 Q99714 1/20 0.82
TSHR P16473 1/20 0.50
GAA P10253 2/20 0.46
ALOX15 P16050 1/20 0.46
MGAM O43451 1/20 0.46
SI P14410 1/20 0.46
MGAM2 Q2M2H8 1/20 0.46
SOAT1 P35610 1/20 0.46
TRPA1 O75762 1/20 0.42
GLO1 Q04760 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
POLB P06746 1/20 0.40
HTT P42858 1/20 0.40
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
CHRM5 P08912 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL1982795 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL15636011 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL5524851 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL4682323 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL1469827 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL14743913 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL2141424 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL5971339 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL12987398 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL1336026 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240216357-A1 POLYCYCLIC COMPOUND AND APPLICATION THEREOF SICHUAN HUIYU PHARMACEUTICAL CO., LTD. (CN) 2024-07-04 US disclosed
CN-118165071-A Oxo-spiro indoline compound and preparation method and application thereof 深圳信立泰药业股份有限公司 2024-06-11 CN disclosed
WO-2024114658-A1 SUBSTITUTED 1-PHENYL-3, 4-DIHYDROPYRIDO [3, 4-D] PYRIMIDIN-2-ONE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2024-06-06 WO disclosed
US-20240174710-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS WAVE LIFE SCIENCES LTD. (SG) 2024-05-30 US disclosed
US-20240175018-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF WAVE LIFE SCIENCES LTD. (SG) 2024-05-30 US disclosed
CN-117924258-A Pyridone compound derivative and application thereof 复旦大学 2024-04-26 CN disclosed
CN-115385921-B Preparation method of thiazole-5-pyrrolopyrrole diketone and conjugated polymer thereof and application of thiazole-5-pyrrolopyrrole diketone as semiconductor material 天津大学 2024-04-16 CN disclosed
US-20240109931-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF WAVE LIFE SCIENCES LTD. (SG) 2024-04-04 US disclosed
CN-117083286-A Pair A 2A A is a 3 Adenosine derivatives having antagonism to adenosine receptor and process for preparing same 未来制药有限公司 2023-11-17 CN disclosed
CN-117062813-A Polycyclic compound and application thereof 四川汇宇制药股份有限公司 2023-11-14 CN disclosed
US-5439932-A Anticholesterol agents BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-08-08 US disclosed
EP-0282895-B1 2-oxa-isocephem compounds, compositions containing same and processes for preparing same OTSUKA PHARMA CO LTD (JP) 1995-06-07 EP disclosed
US-5389663-A Fungicides TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-02-14 US disclosed
US-5306728-A Substituted amine derivatives having antihyperlipemia activity BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-04-26 US disclosed
EP-0215435-B1 2-OXA-ISOCEPHEM COMPOUNDS, COMPOSITIONS CONTAINING SAME AND PROCESSES FOR PREPARING SAME OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-03-03 EP disclosed
EP-0510700-A2 Azole compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-10-28 EP disclosed
EP-0448078-A2 Substituted amine derivatives having anti-hyperlipemia activity BANYU PHARMACEUTICAL CO., LTD. (JP) 1991-09-25 EP disclosed
US-5037976-A Antimicrobial Agent OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-08-06 US disclosed
EP-0282895-A2 2-oxa-isocephem compounds, compositions containing same and processes for preparing same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1988-09-21 EP disclosed
EP-0215435-A1 2-Oxa-isocephem compounds, compositions containing same and processes for preparing same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1987-03-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240175018-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF RNASE1, RNASEH1, RNASEL ALDH1A1 3065/4885LMNA 554/4885HSD17B10 2211/4885
US-20240109931-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF RNASE1, RNASEH1, NSUN3 ALDH1A1 2830/4885LMNA 534/4885HSD17B10 1899/4885
US-20240174710-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS ALKBH1, DUT, RNGTT ALDH1A1 2134/4885LMNA 434/4885HSD17B10 4428/4885
US-20240216357-A1 POLYCYCLIC COMPOUND AND APPLICATION THEREOF KDM1A, TET1, KDM3A ALDH1A1 460/4885LMNA 1527/4885HSD17B10 401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.